Laurus Labs Limited
NDC labeler code: 42385
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- Metformin hydrochlorideGlumetza · 5 products
- GabapentinNeurontin, Gralise, Relgaabi · 5 products
- FenofibrateAntara, Lipofen, Tricor · 4 products
- AtorvastatinLipitor · 4 products
- ValsartanDiovan · 4 products
- PirfenidoneEsbriet · 4 products
- Oseltamivir phosphateTamiflu · 3 products
- AtazanavirReyataz · 3 products
- Sacubitril and valsartanEntresto · 3 products
- Efavirenz, lamivudine and tenofovir disoproxil fumarateSymfi · 2 products
- TicagrelorBrilinta · 2 products
- Lopinavir and ritonavirKaletra · 2 products
- FlucytosineAncobon · 2 products
- Hydroxychloroquine sulfatePlaquenil, Sovuna · 1 product
- MacitentanOpsumit · 1 product
- Emtricitabine and tenofovir disoproxil fumarateTruvada · 1 product
- UrsodiolReltone 200 Mg, Ursolign, Urso Forte · 1 product
- Abacavir and lamivudine1 product
- Efavirenz, emtricitabine and tenofovir disoproxil fumarate1 product
- Rilpivirine hydrochlorideEdurant Ped, Edurant · 1 product
- Emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarateComplera · 1 product
FDA applications for these products
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| August 20, 2026 | ANDA218869 | Ticagrelor TICAGRELOR | Pharmobedient |
| July 10, 2026 | ANDA219788 | Rilpivirine hydrochloride RILPIVIRINE HYDROCHLORIDE | Laurus |
| April 21, 2026 | ANDA218897 | Valsartan VALSARTAN | Pharmobedient |
| March 4, 2026 | ANDA220232 | Emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE | Laurus |
| November 5, 2025 | ANDA211120 | Macitentan MACITENTAN | Laurus |
| July 23, 2025 | ANDA218005 | Flucytosine FLUCYTOSINE | Pharmobedient |
| May 28, 2024 | ANDA213676 | Sacubitril and valsartan SACUBITRIL AND VALSARTAN | Laurus |
| May 1, 2024 | ANDA218565 | Oseltamivir phosphate OSELTAMIVIR PHOSPHATE | Laurus |
| April 8, 2024 | ANDA217965 | Gabapentin GABAPENTIN | Pharmobedient |
| January 22, 2024 | ANDA214513 | Atorvastatin ATORVASTATIN CALCIUM | Laurus |
| October 5, 2023 | ANDA217631 | Metformin hydrochloride METFORMIN HYDROCHLORIDE | Laurus |
| May 12, 2023 | ANDA217546 | Gabapentin GABAPENTIN | Pharmobedient |
| July 25, 2022 | ANDA216332 | Abacavir and lamivudine ABACAVIR SULFATE AND LAMIVUDINE | Laurus |
| July 19, 2022 | ANDA212722 | Pirfenidone PIRFENIDONE | Laurus |
| July 19, 2022 | ANDA212724 | Pirfenidone PIRFENIDONE | Laurus |
| March 21, 2022 | ANDA213857 | Lopinavir and ritonavir LOPINAVIR AND RITONAVIR | Laurus |
| December 22, 2021 | ANDA213541 | Efavirenz, emtricitabine and tenofovir disoproxil fumarate EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE | Laurus |
| April 30, 2021 | ANDA212579 | Atazanavir ATAZANAVIR SULFATE | Laurus |
| May 14, 2020 | ANDA212786 | Efavirenz, lamivudine and tenofovir disoproxil fumarate EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE | Laurus |
| May 14, 2020 | ANDA213038 | Efavirenz, lamivudine and tenofovir disoproxil fumarate EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE | Laurus |
| March 18, 2020 | ANDA211122 | Fenofibrate FENOFIBRATE | Rising |
| February 12, 2020 | ANDA213200 | Ursodiol URSODIOL | Rising |
| July 26, 2019 | ANDA212114 | Emtricitabine and tenofovir disoproxil fumarate EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | Laurus |
| January 15, 2019 | ANDA210959 | Hydroxychloroquine sulfate HYDROXYCHLOROQUINE SULFATE | Laurus |
| August 27, 2018 | ANDA209882 | Metformin hydrochloride METFORMIN HYDROCHLORIDE | Laurus |
Show the other 1 applications
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| August 17, 2018 | ANDA210606 | Fenofibrate FENOFIBRATE | Rising |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
No recall of these products (by NDC code) appears in the FDA enforcement reports.
Next steps
- Find a pharmacy near youAsk which company made your medicine and whether it is recalled
- Latest FDA drug recallsAll companies, newest first
- All drug companiesA to Z
- All prescription drugs A to ZSearch by generic, brand or Spanish name
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026